Showing results (161-170 of 243) with videos related to

Sort By:
Pageof 25
Clinical and Experimental Rheumatology|December 3, 2016
Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registryLorinda Chung, Robert M Fairchild, Daniel E Furst, et al.
Arthritis and Rheumatism|February 3, 2007
The systemic lupus erythematosus Tri-Nation study: cumulative indirect costsPantelis Panopalis, Michelle Petri, Susan Manzi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Identification of a New Susceptibility Locus for Systemic Lupus Erythematosus on Chromosome 12 in Individuals of European AncestryF Yesim Demirci, Xingbin Wang, Jennifer A Kelly, et al.
Lupus Science & Medicine|November 15, 2014
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurementsChaim Putterman, Richard Furie, Rosalind Ramsey-Goldman, et al.
Medicine|February 3, 2018
Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical databaseNadia D Morgan, Ami A Shah, Maureen D Mayes, et al.
Annals of the Rheumatic Diseases|November 27, 2019
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profileBrian Skaug, Dinesh Khanna, William R Swindell, et al.
The Journal of Rheumatology|August 4, 2005
Severity of joint pain and Kellgren-Lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritisSteven A Mazzuca, Kenneth D Brandt, Donald S Schauwecker, et al.
The Journal of Rheumatology|November 3, 2015
Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical PracticesJoyce S Hui-Yuen, Arthi Reddy, Jennifer Taylor, et al.
The Lancet. Rheumatology|December 30, 2021
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trialLorinda Chung, Cathie Spino, Richard McLain, et al.
Lupus Science & Medicine|May 7, 2020
Cell-bound complement activation products associate with lupus severity in SLECristina Arriens, Roberta Vezza Alexander, Sonali Narain, et al.
Pageof 25